Tonix Pharmaceuticals Stock News

First-in-Human Study Expected to be Initiated in the First Quarter of 2022

First-in-Human Study Expected to be Initiated in the First Quarter of 2022 An Approved Test Would Lead to Identification of People Requiring Vaccine Boosters CHATHAM, N.J., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP ) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to initiate a first-in-human clinical study for TNX-2100 (SARS-CoV-2 epitope peptide mixtures for intradermal administration), a skin test to measure delayed-type hypersensitivity (DTH) to SARS-CoV-2 (CoV-2), the virus that causes COVID-19. DTH is a measure of T cell immunity. Tonix expects to initiate the clinical study in the first quarter of 2022. "When fully developed, our proposed skin test has the potential to provide clinicians, patients, employers and public health officials with important diagnostic, safety and predictive information, including the durability of immune responses in vaccinated, convalescent and exposed individuals," stated Seth Lederman, M.D., President and Chief Executive Officer of Tonix. "One of the goals of clinical development of TNX-2100 will be to study the potential correlation of a positive skin test with protective immunity.

The trading price of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) closed lower on Friday, December 10, closing at $0.38, -4.42% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) with the stream of -4.42% also noticed, India Trevi Therapeutics, Inc. (NASDAQ:TRVI) encountered a rapid change of 0.40% in the last hour of Fridays trading The post Hot Stocks Highlights: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Trevi Therapeutics, Inc. (NASDAQ:TRVI) appeared first on Stocks Equity .

Millennium Management LLC lowered its stake in shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) by 15.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 830,208 shares of the companys stock after selling 154,243 shares during the quarter. Millennium Management LLCs []

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)s traded shares stood at 25.52 million during the last session, with the companys beta value hitting 1.15. At the close of trading, the stocks price was $0.40, to imply a decrease of -10.26% or -$0.05 in intraday trading. The TNXP shares 52-week high remains $2.12, putting it -430.0% down since Stock Of Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Dropped By -32.00 Percent Over The Past Month, Is There Room For Downside? Read More »

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post What You Absolutely Cant Miss: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP -10.26%), Stealth BioTherapeutics Corp (NASDAQ:MITO -2.64%) appeared first on Stocks Equity .

Tonix Pharmaceuticals Holding Corp. (TNXP) with the stream of -5.21% also noticed, India Kinross Gold Corporation (KGC) encountered a rapid change of 0.69% in the last hour of trading session. The post Stock Jumping on Abnormally High Volume: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Kinross Gold Corporation (NYSE:KGC) appeared first on Stocks Equity .

Tonix Pharmaceuticals Holding Corp. (TNXP) with the stream of -5.21% also noticed, India Dow Inc. (DOW) encountered a rapid change of -0.21% in the last hour of Fridays trading session. The post Is The Stock Worthy? Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Dow Inc. (NYSE:DOW) appeared first on Stocks Equity .

Tonix Pharmaceuticals Holding Corp. (TNXP) with the stream of 6.18% also noticed, India Teva Pharmaceutical Industries Limited (TEVA) encountered a rapid change of -2.19% in the last hour of trading The post Comprehensive Stock Analysis: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Teva Pharmaceutical Industries Limited (NYSE:TEVA) appeared first on Stocks Equity .

State Street Corp boosted its stake in shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) by 6,469.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,097,793 shares of the companys stock after purchasing an additional 5,020,193 shares during the []

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares, rose in value on Wednesday, 11/24/21, with the stock price down by -2.58% to the previous days close as strong demand from buyers drove the stock to $0.48. Actively observing the price movement in the last trading, the stock closed the session at $0.49, falling within a range of What Analysts Were Expecting After Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) fell -2.58% Read More »

Equities analysts predict that Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) will announce ($0.08) earnings per share for the current quarter, Zacks reports. Zero analysts have issued estimates for Tonix Pharmaceuticals earnings, with estimates ranging from ($0.08) to ($0.07). Tonix Pharmaceuticals posted earnings of ($0.10) per share in the same quarter last year, which suggests a positive []

Tonix Pharmaceuticals Holding Corp. (TNXP) with the stream of -2.38% also noticed, India Marathon Oil Corporation (MRO) encountered a rapid change of 2.12% in the last hour of Wednesdays trading The post Trending Hot Stocks Analysis: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Marathon Oil Corporation (NYSE:MRO) appeared first on Stocks Equity .

The company's path to regulatory approval for a key pipeline drug just got a bit shorter.